Subject(s)
AIDS Serodiagnosis , Mass Screening , AIDS Serodiagnosis/economics , AIDS Serodiagnosis/statistics & numerical data , Adolescent , Adult , Aged , Ecuador/epidemiology , Female , HIV Infections/diagnosis , HIV Infections/epidemiology , HIV Seroprevalence , Health Services Accessibility , Health Services Needs and Demand , Humans , Male , Middle Aged , Private Practice , Public Health Practice , Risk Factors , Young AdultABSTRACT
Resumo Foz do Iguaçu participa do SIS-Fronteiras e instalou o Centro Materno Infantil (CMI), ofertando atendimento ao pré-natal das gestantes brasileiras moradoras no Paraguai (brasiguaias). Para analisar as características do CMI e comparar o perfil de brasiguaias com gestantes brasileiras residentes no Brasil, conciliou-se abordagem quanti-qualitativa na metodologia. Verificou-se que gestantes brasiguaias atendidas no CMI procuram o local devido à precariedade do sistema de saúde paraguaio. Elas são mais jovens, apresentam maior paridade, menor escolaridade e não têm companheiro, quando comparadas às moradoras no Brasil. Elas omitem onde moram, tentando minimizar a possiblidade de terem atendimento inferior ao das brasileiras do local, ou terem negado seu direito à consulta; e buscam o serviço de obstetrícia tardiamente para evitar a negativa do atendimento. Elas geram custo alto para o município, sobretudo pela desinformação sobre a sua história reprodutiva e gestacional, o que aumenta as chances de serem submetidas a parto cesáreo e de internação da mãe e/ou do bebê, por complicações. Ações efetivas em relação à saúde materno-infantil nas zonas de fronteira precisam ser priorizadas.
Abstract Foz do Iguaçu participates in the SIS-Fronteiras program and installed the Maternal and Child Care Center (CMI) to offer prenatal care service to pregnant Brazilian women resident in Paraguay (Brasiguaias). To analyze the characteristics of the CMI and compare the profile of Brasiguaias with pregnant Brazilian women resident in Brazil, a quantitative and qualitative approach in methodology was applied. It was found that Brasiguaias go to the CMI because of the precariousness of services of the Paraguayan Health System. They tend to be younger, bear more children, have lower education and are unmarried compared with pregnant Brazilian woman resident in Brazil. They omit where they live to avoid being denied the right or receiving inferior treatment than local pregnant Brazilian women and seek obstetric treatment later to avoid being denied attendance. Pregnant Brazilian women resident in Paraguay are onerous to the municipality, especially due to misinformation about their reproductive and pregnancy history, which increases the chances of undergoing cesarean delivery and hospitalization of the mother and/or infant due to complications. Effective actions in relation to maternal and child health in the border areas need to be prioritized.
Subject(s)
Humans , AIDS Serodiagnosis/economics , Emergency Service, Hospital/standards , Occupational Exposure , AIDS Serodiagnosis/methods , Costs and Cost Analysis , Enzyme-Linked Immunosorbent Assay/economics , Retrospective StudiesABSTRACT
INTRODUCTION: The Argentinean AIDS Program estimates that 110,000 persons are living with HIV/AIDS in Argentina. Of those, approximately 40% are unaware of their status, and 30% are diagnosed in advanced stages of immunosuppression. Though studies show that universal HIV screening is cost-effective in settings with HIV prevalence greater than 0.1%, in Argentina, with the exception of antenatal care, HIV testing is always client-initiated. OBJECTIVE: We performed a pilot study to assess the acceptability of a universal HIV screening program among inpatients of an urban public hospital in Buenos Aires. METHODS: Over a six-month period, all eligible adult patients admitted to the internal medicine ward were offered HIV testing. Demographics, uptake rates, reasons for refusal and new HIV diagnoses were analyzed. RESULTS: Of the 350 admissions during this period, 249 were eligible and subsequently enrolled. The enrolled population was relatively old compared to the general population, was balanced on gender, and did not report traditional high risk factors for HIV infection. Only 88 (39%) reported prior HIV testing. One hundred and ninety (76%) patients accepted HIV testing. In multivariable analysis only younger age (OR 1.02; 95%CI 1.003-1.05) was independently associated with test uptake. Three new HIV diagnoses were made (undiagnosed HIV prevalence: 1.58%); none belonged to a most-at-risk population. CONCLUSIONS: Our findings suggest that universal HIV screening in this setting is acceptable and potentially effective in identifying undiagnosed HIV-infected individuals. If confirmed in a larger study, our findings may inform changes in the Argentinean HIV testing policy.
Subject(s)
AIDS Serodiagnosis/methods , HIV Infections/diagnosis , Inpatients/statistics & numerical data , Mass Screening/methods , AIDS Serodiagnosis/economics , Adult , Aged , Argentina/epidemiology , Cost-Benefit Analysis , Female , HIV Infections/epidemiology , HIV Infections/virology , Hospitals, Public/statistics & numerical data , Hospitals, Urban/statistics & numerical data , Humans , Logistic Models , Male , Mass Screening/economics , Middle Aged , Patient Acceptance of Health Care/statistics & numerical data , Pilot Projects , Prevalence , Prospective StudiesABSTRACT
Minimum accuracy of HIV diagnostic tests is considered the pillar on which testing strategies for all settings must be based. Systematic reviews and meta-analyses have shown that performance of the same test in different settings may vary according to several factors, resulting in different confidence intervals for sensitivity and specificity. Prevalence of HIV infection may influence observed test accuracy. The purpose of this article is to use the knowledge from meta-analyses of general diagnostic tests to inform the specific field of HIV diagnostic strategies. We propose the 'Bayesian' thinking: considering the pretest probability (i.e., prevalence, risk factors) and understanding test limitations to estimate a post-test probability of HIV diagnosis. Cost-effectiveness analysis, patient preferences and ethical issues must also be considered in HIV testing strategies.
Subject(s)
AIDS Serodiagnosis/methods , AIDS Serodiagnosis/standards , HIV Infections/diagnosis , AIDS Serodiagnosis/economics , Algorithms , Bayes Theorem , Cost-Benefit Analysis , HIV Infections/epidemiology , Humans , Male , Meta-Analysis as Topic , Predictive Value of Tests , Prevalence , Risk Factors , Sensitivity and SpecificityABSTRACT
OBJETIVO: Comparar mediante un modelo de análisis de decisiones tres estrategias de tamizaje de la infección por el VIH en mujeres embarazadas según su relación costo-efectividad y proponer la más apropiada para el sistema de salud colombiano. MÉTODOS: Estudio económico basado en el análisis mediante árboles de decisión según tres estrategias de tamizaje de la infección por el VIH en mujeres embarazadas: la voluntaria, la universal y la opcional. Se consideró a todas las mujeres colombianas embarazadas sin diagnóstico de infección por el VIH que se presentaban para el parto. Se emplearon los costos médicos directos desde la realización de la prueba hasta un año después del parto, según el Sistema General de Seguridad Social en Salud. Se compararon las razones costo-efectividad y el ahorro de cada estrategia analizada. RESULTADOS: Por cada 10 000 mujeres, la estrategia universal permitió detectar 5 casos más que la estrategia voluntaria y 7 casos más que la opcional. La estrategia universal generó costos aproximados de US$ 17,00 por cada recién nacido positivo, es decir, menos de la mitad que lo calculado para la estrategia voluntaria (US$ 38,00) y menor que para la opcional (US$ 24,00). Según el análisis bifactorial, la estrategia de tamizaje universal fue menos costosa que la voluntaria y más efectiva que las otras dos estrategias, independientemente de la prevalencia, la tasa de positivos falsos del sistema de diagnóstico empleado y la tasa de aceptación materna para realizarse la prueba de tamizaje. CONCLUSIONES: La estrategia de tamizaje voluntaria, que se utiliza actualmente en Colombia, es más costosa que la universal a mediano y largo plazos y tiene menor efectividad y capacidad de prevención. Se recomienda a las autoridades nacionales de salud realizar el tamizaje de la infección por el VIH a todas las embarazadas colombianas con pruebas de tercera generación.
OBJECTIVES: To apply decision analysis to compare the cost-effectiveness of three strategies for HIV screening of pregnant women and to recommend the one most appropriate for the health care system of Colombia. METHODS: An economic study applying decision analysis to three types of HIV screening of expectant women: voluntary, universal, and optional. All the women in Colombia with unknown HIV status who were admitted for child birth were included. The study included all the direct medical costs incurred from the time of testing through the first year following delivery, according to the General System for Healthcare Social Security. Cost-effectiveness ratio and the savings of each of the strategies were compared. RESULTS: For every 10 000 women, the universal strategy detected five cases more than the voluntary strategy and seven cases more than the optional. The universal strategy carried a cost of approximately US$ 17 for each HIV-positive newborn; that is, less than half of that of the voluntary strategy (US$ 38) and less than the optional (US$ 24). According to the bifactorial analysis, the universal screening strategy was less costly than the voluntary and more effective than both of the others, regardless of prevalence, the false-positive rate of each method, and the rate of maternal compliance with screening. CONCLUSIONS: The screening strategy currently in use in Colombia is more costly (in both the medium- and long-term), less effective, and less capable of prevention, than the universal screening strategy. The recommendation to the national health authorities of Colombia is to begin screening all pregnant women for HIV infection using third-generation testing.
Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Adult , AIDS Serodiagnosis/methods , HIV Infections/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Mandatory Testing , Mass Screening/methods , Patient Acceptance of Health Care , Pregnancy Complications, Infectious/diagnosis , Prenatal Care/methods , Voluntary Programs , AIDS Serodiagnosis/economics , Blotting, Western/economics , Colombia/epidemiology , Costs and Cost Analysis , Decision Trees , Enzyme-Linked Immunosorbent Assay/economics , False Positive Reactions , HIV Infections/congenital , HIV Infections/drug therapy , HIV Infections/economics , HIV Infections/epidemiology , HIV Infections/transmission , Infectious Disease Transmission, Vertical/economics , Mandatory Testing/economics , Mass Screening/economics , Polymerase Chain Reaction/economics , Pregnancy Complications, Infectious/economics , Pregnancy Complications, Infectious/epidemiology , Prenatal Care/economics , Voluntary Programs/economicsABSTRACT
OBJECTIVES: To apply decision analysis to compare the cost-effectiveness of three strategies for HIV screening of pregnant women and to recommend the one most appropriate for the health care system of Colombia. METHODS: An economic study applying decision analysis to three types of HIV screening of expectant women: voluntary, universal, and optional. All the women in Colombia with unknown HIV status who were admitted for child birth were included. The study included all the direct medical costs incurred from the time of testing through the first year following delivery, according to the General System for Healthcare Social Security. Cost-effectiveness ratio and the savings of each of the strategies were compared. RESULTS: For every 10,000 women, the universal strategy detected five cases more than the voluntary strategy and seven cases more than the optional. The universal strategy carried a cost of approximately US$ 17 for each HIV-positive newborn; that is, less than half of that of the voluntary strategy (US$ 38) and less than the optional (US$ 24). According to the bifactorial analysis, the universal screening strategy was less costly than the voluntary and more effective than both of the others, regardless of prevalence, the false-positive rate of each method, and the rate of maternal compliance with screening. CONCLUSIONS: The screening strategy currently in use in Colombia is more costly (in both the medium- and long-term), less effective, and less capable of prevention, than the universal screening strategy. The recommendation to the national health authorities of Colombia is to begin screening all pregnant women for HIV infection using third-generation testing.
Subject(s)
AIDS Serodiagnosis/methods , HIV Infections/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Mandatory Testing , Mass Screening/methods , Patient Acceptance of Health Care , Pregnancy Complications, Infectious/diagnosis , Prenatal Care/methods , Voluntary Programs , AIDS Serodiagnosis/economics , Adult , Blotting, Western/economics , Colombia/epidemiology , Costs and Cost Analysis , Decision Trees , Enzyme-Linked Immunosorbent Assay/economics , False Positive Reactions , Female , HIV Infections/congenital , HIV Infections/drug therapy , HIV Infections/economics , HIV Infections/epidemiology , HIV Infections/transmission , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/economics , Male , Mandatory Testing/economics , Mass Screening/economics , Polymerase Chain Reaction/economics , Pregnancy , Pregnancy Complications, Infectious/economics , Pregnancy Complications, Infectious/epidemiology , Prenatal Care/economics , Voluntary Programs/economicsABSTRACT
OBJECTIVE: To estimate and compare the cost-effectiveness of selected interventions to reduce mother-to-child transmission (MTCT) of HIV in Mexico. METHODS: A spreadsheet-based model was used to examine five scenarios, each estimated using both zidovudine (ZDV) and nevirapine (NVP). Scenarios differ according to coverage, type of voluntary counselling and testing (VCT), restriction to women at higher risk, and whether rapid testing is offered at delivery. Averted adult infections due to VCT are also estimated, as are savings due to averted treatment costs. Results are reported as cost per child infection prevented, net of averted treatment costs (C/CIP). RESULTS: Among 958294 women attending public antenatal clinics, increasing VCT coverage from 4% to 85% is estimated to prevent 102 paediatric and 8 adult infections at a C/CIP of US dollars 42517 using ZDV. In the most restrictive scenario (III), 46 paediatric infections are prevented with a C/CIP of US dollars 39220. Use of NVP increases C/CIP because the reduced drug cost is more than offset by its reduced assumed effectiveness. The cost of detecting infected women (approximately 90% of total) far exceeds treatment costs in such a low-prevalence setting. CONCLUSION: Minimization of MTCT costs in low-prevalence settings should focus on VCT costs rather than drug costs. Even the most cost-effective scenario modelled compares unfavourably with other, highly cost-effective maternal/child interventions that still do not reach many Mexicans. However, it compares favourably against several therapeutic maternal/child interventions available in the public sector's tertiary care hospitals.
Subject(s)
AIDS Serodiagnosis/economics , Cost of Illness , HIV Infections/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious/prevention & control , Prenatal Care/economics , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/economics , Breast Feeding , Cesarean Section/economics , Cost-Benefit Analysis , Counseling/economics , Female , HIV Infections/economics , HIV Infections/epidemiology , HIV Infections/transmission , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical/economics , Mexico/epidemiology , Nevirapine/administration & dosage , Nevirapine/economics , Pregnancy , Pregnancy Complications, Infectious/economics , Pregnancy Complications, Infectious/epidemiology , Prenatal Care/methods , Value of Life/economics , Zidovudine/administration & dosage , Zidovudine/economicsABSTRACT
In occupational accidents involving health professionals handling potentially contaminated material, the decision to start or to continue prophylactic medication against infection by Human Immunodeficiency Virus (HIV) has been based on the ELISA test applied to a blood sample from the source patient. In order to rationalize the prophylactic use of antiretroviral agents, a rapid serologic diagnostic test of HIV infection was tested by the enzymatic immunoabsorption method (SUDS HIV 1+2, MUREX) and compared to conventional ELISA (Abbott HIV-1/ HIV-2 3rd Generation plus EIA). A total of 592 cases of occupational accidents were recorded at the University Hospital of Ribeirão Preto from July 1998 to April 1999. Of these, 109 were simultaneously evaluated by the rapid test and by ELISA HIV. The rapid test was positive in three cases and was confirmed by ELISA and in one the result was inconclusive and later found to be negative by ELISA. In the 106 accidents in which the rapid test was negative no prophylactic medication was instituted, with an estimated reduction in costs of US$ 2,889.35. In addition to this advantage, the good correlation of the rapid test with ELISA, the shorter duration of stress and the absence of exposure of the health worker to the adverse effects of antiretroviral agents suggest the adoption of this test in Programs of Attention to Accidents with Potentially Contaminated Material.
Subject(s)
AIDS Serodiagnosis/methods , Accidents, Occupational , Health Personnel , AIDS Serodiagnosis/economics , Anti-HIV Agents/economics , Anti-HIV Agents/therapeutic use , Enzyme-Linked Immunosorbent Assay , Equipment Contamination , HIV Infections/prevention & control , HumansABSTRACT
Compares the effectiveness of voluntary counselling and testing for AIDS or reproductive health education among people in Kenya, Tanzania and Trinidad. Changes in sexual behaviour that occured among individuals in the counselling and testing group; Reports in this issue of the Lancet that deal with AIDS vaccines in developing countries and the cost-effectiveness of counselling and testing for HIV and AIDS.(Au)
Subject(s)
Humans , AIDS Serodiagnosis , Community Health Services/organization & administration , Counseling/organization & administration , HIV Infections/diagnosis , HIV Infections/prevention & control , AIDS Serodiagnosis/economics , Cost-Benefit Analysis , Health Knowledge, Attitudes, Practice , Needs Assessment , Sexual Behavior/physiology , Sexual Behavior/statistics & numerical dataABSTRACT
The use of sera mixtures for the detection of HIV antibodies was studied in a population of low prevalence (0.006%), using the diagnosis systems of national production: Recombinant HIV UMELISA and RECHIV 1 + 2. The systems were evaluated with individual samples and mixtures of 5 and 10 sera from healthy blood donors and from HIV-1 and/or HIV-2 positive and undetermined persons. It was observed that the utilization of mixtures of 10 sera is not feasible; however, the use of mixtures of 5 affects neither the specificity nor the sensitivity of the systems studied.
Subject(s)
AIDS Serodiagnosis/methods , HIV Antibodies/blood , HIV-1/immunology , AIDS Serodiagnosis/economics , Blood Donors , Developing Countries , Enzyme-Linked Immunosorbent Assay , Feasibility Studies , HIV Seroprevalence , HIV-2/immunology , Humans , Sensitivity and SpecificityABSTRACT
The goal of this study is to increase the knowledge of the AIDS cost in a hospital. We have studied the HIV patients diagnosed during a year in our hospital and the charges of the serological tests performed to them. 20.8% of the tests were to study antibodies against HIV (only 20% were positive). After patient distribution between extra or intrahospital origin, we highlight that 61% of the charges are attributed to patients who do not belong to the hospital but to its catchment area. We emphasize the problem that AIDS patients are creating to hospital, being necessary that personal select only useful tests honestly.
Subject(s)
AIDS Serodiagnosis/economics , HIV Seropositivity/complications , Hospitals, University/economics , Immunologic Tests/economics , Infections/complications , AIDS Serodiagnosis/statistics & numerical data , Acquired Immunodeficiency Syndrome/economics , Antibodies/analysis , Catchment Area, Health , Costs and Cost Analysis , HIV Antibodies/analysis , HIV Seropositivity/diagnosis , Humans , Immunologic Tests/statistics & numerical data , Infections/diagnosis , Prisons , Substance Abuse Treatment CentersABSTRACT
Due to the presence of the acquired immune deficiency syndrome (AIDS), it has been frequently stated, by several segments of the society, that mandatory human immunodeficiency virus (HIV) testing as premarital requirement is useful for AIDS prevention. The usefulness of these tests among general population are discussed, as well as some problems for its eventual implementation, concluding that this screening procedure is impractical, inefficient and expensive as a public health measure. The overall HIV prevalence in Mexico is very low (4 per 10,000), therefore, a person from this population with a positive screening test, has a slight chance of being truly infected (16%), in other words, screening tests have a low positive predictive value in general population. Conversely, having a negative screening test, predicts this state accurately (negative predictive value greater than 99%). Several problems arise when HIV screening tests are applied: logistics, for example avoidance of the tests, economic, ethic, and human rights problems, among others. It is concluded that mandatory HIV screening tests are not cost-efficient and that there are other options, for instance education, which would imply better changes for HIV prevention.